Binder profile
CBW
Bioactivity hit from ChEMBL on a similar protein.
Bound to: PA1330 — short-chain dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
CBW- UniProt (similar protein)
P80365- pchembl
- 8.920
- Target protein
- PA1330
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 470.7
- LogP ≤ 5 6.41
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 74.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC1([C@@H]2CC[C@@]3([C@@H]([C@]2(CC[C@@H]1O)C)C(=O)C=C4[C@]3(CC[C@@]5([C@H]4C[C@@](CC5)(C)C(=O)O)C)C)C)CCC1([C@@H]2CC[C@@]3([C@@H]([C@]2(CC[C@@H]1O)C)C(=O)C=C4[C@]3(CC[C@@]5([C@H]4C[C@@](CC5)(C)C(=O)O)C)C)C)C
InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1
MPDGHEJMBKOTSU-YKLVYJNSSA-NMPDGHEJMBKOTSU-YKLVYJNSSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF00106
External resources
Open this ligand in third-party databases and cheminformatics tools.
- UniProt UniProt P80365 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CBW”) →
Other binders for this protein
Quick navigation to other ligands bound to PA1330.
PDB 16
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).